跳至主要内容
临床试验/NCT02073734
NCT02073734已完成3 期

Effects of Preoperative Dexamethasone on Postoperative Quality of Recovery Following Vaginal Reconstructive Surgery: A Randomized Controlled Trial

TriHealth Inc.1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2013年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
63
试验地点
1
主要终点
The primary endpoint will be scores on the 40- item quality of recovery scoring system (QoR-40).

研究概览

简要总结

The investigators hypothesize that preoperative administration of 8 mg IV dexamethasone will benefit patients' perceived quality of recovery after surgery.

详细描述

This is a randomized controlled trial involving single administration of 8 mg Dexamethasone per IV preoperatively among women undergoing vaginal reconstructive surgery for pelvic organ prolapse.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 81 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 18-81 years old who are scheduled to undergo a major vaginal reconstructive surgery, including hysterectomy with or without hysterectomy

排除标准

  • Daily use of steroids or antiemetic agents such as Zofran, Reglan, Compazine and Phenargan within one month of surgery
  • Regional anesthesia for surgical procedure
  • Chronic pain requiring opioid treatment daily
  • History of allergy to the study medication
  • Severe renal and liver disease
  • Pregnancy
  • Non English speaking
  • Psychiatric disorder that will preclude completion of questionnaires
  • Minor surgery that does not involve overnight admission
  • Surgery that does not involve hysterectomy or vaginal intraperitoneal apical suspension
  • Hypersensitivity reaction to steroids
  • Evidence of systemic fungal infection
  • Evidence of any systemic infection
  • Uncontrolled diabetes

研究组 & 干预措施

Dexamethasone

Experimental

Dexamethasone

干预措施: Dexamethasone (Drug)

Placebo

Placebo Comparator

Sterile normal saline solution

干预措施: Placebo (Drug)

结局指标

主要结局

The primary endpoint will be scores on the 40- item quality of recovery scoring system (QoR-40).

时间窗: up to 20-24 hours after surgery

The QoR-40 is a validated standardized questionnaire that assesses the dimensions of physical functioning, mental health, cognitive functioning, symptoms, role and social functioning, general health perceptions, sleep and energy

次要结局

  • To determine if dexamethasone has positive impact on other clinical recovery variables such as nausea, vomiting and pain.(20-24 hours after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验